ライフサイエンスコーパス: septal defect

1 Fallot or pulmonary atresia with ventricular septal defect.

2 th the pathogenesis of atrioventricular (AV) septal defect.

3 tricuspid atresia and large secundum atrial septal defect.

4 oplasia, hypertrabeculation, and ventricular septal defect.

5 uble-outlet right ventricle, and ventricular septal defect.

6 function, and had no evidence of ventricular septal defect.

7 ight ventricle with a concurrent ventricular septal defect.

8 birth with lung hypoplasia and a ventricular septal defect.

9 other cardiac defects including ventricular septal defect.

10 eptum and 298 (38%) for TGA with ventricular septal defect.

11 arge family with dominantly inherited atrial septal defect.

12 pproaches for simple lesions, such as atrial septal defect.

13 onding to surgical closure of a large atrial septal defect.

14 d efficacy of device closure of large atrial septal defects.

15 and perimembranous and muscular ventricular septal defects.

16 tium primum defect, a hallmark feature of AV septal defects.

17 humans, including dilated cardiomyopathy and septal defects.

18 iciency in mice could cause atrioventricular septal defects.

19 at different loci for atrial and ventricular septal defects.

20 7Bl/6 frequently have atrial and ventricular septal defects.

21 defects and C57Bl/6 to muscular ventricular septal defects.

22 uble outlet right ventricles and ventricular septal defects.

23 ction affect muscular ventricular and atrial septal defects.

24 ular septum and display profound ventricular septal defects.

25 e with thin ventricular wall and ventricular septal defects.

26 ed with the pathogenesis of atrioventricular septal defects.

27 , pulmonary artery stenosis, and ventricular septal defects.

28 rterial trunk and perimembranous ventricular septal defects.

29 for percutaneous closure of secundum atrial septal defects.

30 s and between ozone and isolated ventricular septal defects.

31 ventricular (VSD) or atrioventricular (AVSD) septal defects.

32 w tract alignment and membranous ventricular septal defects.

33 pecific defects, prevalence was greatest for septal defects.

34 ts paralog Hoxa1 results in atrioventricular septal defects.

35 n and between sertraline use and ventricular septal defects.

36 yndrome but inversely associated with atrial septal defects.

37 % CI, -0.74 to -0.09); and major ventricular septal defects, -0.25 (95% CI, -0.35 to -0.15).

38 interval, -0.87 to -0.10); major ventricular septal defects, -0.41 (95% confidence interval, -0.52 to

39 association was significant for ventricular septal defects (1.1% vs 0.6%; P = .001) and other CHDs (

40 premature CAD (OR for CoA versus ventricular septal defect, 1.44; 95% CI, 0.79-2.64) after adjustment

41 9 kindreds with familial CHD, 4 with atrial septal defects, 2 with patent ductus arteriosus, 2 with

42 iagnoses included tetralogy of Fallot (51%), septal defects (20%), (congenitally corrected) transposi

43 tricular septal defects (22/47, 47%), atrial septal defects (20/47, 43%), patent ductus arteriosus (1

44 rdiovascular anomalies, of which ventricular septal defects (22/47, 47%), atrial septal defects (20/4

45 400 patients, 154 (38.3%) with a ventricular septal defect, 238 (59.5%) with an intact septum, and 9

46 d with 224 of 6481 patients with ventricular septal defect (4.9% versus 3.5%; P=0.04).

47 the great arteries (8%), ventricular/atrial septal defects (8%), left ventricular outflow obstructio

48 Final QIs included: 8 for atrial septal defects; 9 for aortic coarctation; 12 for Eisenme

49 ural crest such as cleft palate, ventricular septal defect, abnormal development of hypoglossal nerve

50 ng aortic coarctation, ventricular or atrial septal defect, abnormal mitral valve, aortic root dilati

51 highest risk of IE in comparison with atrial septal defects (adjusted rate ratio, 95% confidence inte

52 ion, with d-TGA, with or without ventricular septal defects, admitted to our institution at 5 days of

53 right ventricle, and atrial and ventricular septal defects, all occurring with variable penetrance.

54 -) embryos revealed a membranous ventricular septal defect and an abnormal nodule of cartilage within

55 ulting from a profound subaortic ventricular septal defect and associated malalignment of the outflow

56 that confer greater susceptibility to atrial septal defect and atrioventricular septal defects and C5

57 cts, including liver hypotrophy, ventricular septal defect and haemorrhage.

58 icus, congestive heart failure due to atrial septal defect and hypernatremic dehydration due to diabe

59 ovascular development, including ventricular septal defect and non-compaction, as well as outflow tra

60 to-right shunting in the form of ventricular septal defect and paradoxical thromboembolism.

61 iduals with DS and complete atrioventricular septal defect and sequenced 2 candidate genes for CHD: C

62 severe, excluding cases with isolated atrial septal defect and/or patent foramen ovale.

63 igh penetrance, large membranous ventricular septal defects and a bifid cardiac apex, and less freque

64 ryonic death, but does result in ventricular septal defects and a low incidence of semilunar valve de

65 formations, including ventricular and atrial septal defects and a thin ventricular myocardium.

66 though human mutation of NKX2-5 is linked to septal defects and atrioventricular conduction abnormali

67 between carbon monoxide and isolated atrial septal defects and between ozone and isolated ventricula

68 may contribute to the development of atrial septal defects and bicuspid aortic valves.

69 nt in magnitude were detected between atrial septal defects and bromoform (aOR = 1.56; 95% CI: 1.01,

70 to atrial septal defect and atrioventricular septal defects and C57Bl/6 to muscular ventricular septa

71 Most cases of atrial septal defects and cardiomyopathy are not associated wit

72 ce, is a candidate causative gene for atrial septal defects and cardiomyopathy.

73 diogenic transcription factor, cause cardiac septal defects and cardiomyopathy.

74 xclusively to Lipid II binding, which causes septal defects and catastrophic cell envelope damage.

75 ts with CHD7 mutations, but atrioventricular septal defects and conotruncal heart defects are over-re

76 escribes the clinical aspects of ventricular septal defects and current management strategies.

77 , p.G115W, was identified in familial atrial septal defects and demonstrated decreased transactivatio

78 tion resulted in atrial and atrioventricular septal defects and hypoplasia of the developing DMP.

79 ct device for use in multifenestrated atrial septal defects and the fenestrated atrial septal defect

80 AC9 show a propensity for lethal ventricular septal defects and thin-walled myocardium.

81 cription factor gene, cause atrioventricular septal defects and valve abnormalities by disrupting a s

82 tidiastole of coronary heart disease, atrial septal defect, and atrial fibrillation are made, and the

83 of Fallot, overriding aorta with ventricular septal defect, and bicuspid aortic valves.

84 luding hypoplasia of myocardium, ventricular septal defect, and disorganized morphology.

85 poplastic myocardium, membranous ventricular septal defect, and double outlet right ventricle.

86 ncluding Ebstein's anomaly, atrioventricular septal defect, and others.

87 malities of the tricuspid valve, ventricular septal defect, and pulmonary stenosis, occur in the majo

88 yndrome of progressive RCM, atrioventricular septal defects, and a high prevalence of atrial fibrilla

89 d myocardium, ventricular and aortopulmonary septal defects, and abnormal smooth muscle development.

90 ble-outlet right ventricle, atrioventricular septal defects, and caval vein abnormalities.

91 elopment, bicuspid aortic valve, ventricular septal defects, and embryonic lethality.

92 such as cleft-lip and cleft-palate, cardiac septal defects, and eye defects.

93 embryos had a double outlet RV, ventricular septal defects, and hypertrophic myopathy, with near obl

94 ll, pulmonary-artery hypoplasia, ventricular septal defects, and hypoplastic left heart.

95 g double outlet right ventricle, ventricular-septal defects, and pericardial edema.

96 excluding ventricular septal defects, atrial septal defects, and pulmonary valve stenosis) occurred i

97 , double-outlet right ventricle, ventricular septal defects, and thin-walled myocardium.

98 ogenesis, reduced ventricular trabeculation, septal defects, and valvular overgrowth.

99 aOR = 1.28; 95% CI: 1.03, 1.61), ventricular septal defect (aOR = 1.19; 95% CI: 1.00, 1.43), and tetr

100 al atresia/stenosis (aOR = 2.48), and atrial septal defect (aOR = 1.37).

101 sitively associated with the risks of atrial septal defect (aORs ranging from 1.29 to 2.17), patent d

102 ollutants and daily risks of secundum atrial septal defect, aortic coarctation, hypoplastic left hear

103 Most children with isolated atrial septal defects are free of symptoms, but the rates of ex

104 Conotruncal defects and atrioventricular septal defects are over-represented in patients with CHD

105 Ventricular septal defects are the most common congenital heart defe

106 Atrial septal defects are the third most common type of congeni

107 s (aRR, 0.85; 95% CI, 0.75-0.96), and atrial septal defects (aRR, 0.82; 95% CI, 0.69-0.95) but not se

108 (aRR, 0.77; 95% CI, 0.61-0.96), ventricular septal defects (aRR, 0.85; 95% CI, 0.75-0.96), and atria

109 n a cohort of patients with atrioventricular septal defects as a part of Ellis van Creveld syndrome (

110 d male lethal condition encompassing cardiac septal defects, as well as ocular and dental anomalies.

111 Only one atrial septal defect (ASD) and two patent ductus arteriosus (PD

112 We compared administrative data for atrial septal defect (ASD) and ventricular septal defect (VSD)

113 ks is a complication of transcatheter atrial septal defect (ASD) closure.

114 Familial atrial septal defect (ASD) has previously been attributed prima

115 (7)) with the risk of ostium secundum atrial septal defect (ASD) in the discovery cohort (N = 340 cas

116 Secundum atrial septal defect (ASD) is the most common adult congenital

117 n cause an autosomal dominant form of atrial septal defect (ASD), whereas others have identified muta

118 ccluder (HSO) with surgical repair of atrial septal defect (ASD).

119 solated procedures: device closure of atrial septal defect (ASD); device closure of patent ductus art

120 permanent synthetic implants to close atrial septal defects (ASD) and patent foramen ovale (PFO) has

121 e embryo and persistent ostium primum atrial septal defects (ASD) in approximately 20% of adults.

122 1 and STX18, has been associated with atrial septal defects (ASD) in multiple European and Chinese co

123 ysiology and 12 control patients with atrial septal defects (ASD) that underwent cardiac catheterizat

124 Transcatheter closure of secundum atrial septal defects (ASD) using the Amplatzer septal occluder

125 ive therapeutic option for congenital atrial septal defects (ASD).

126 transposition of the great arteries, atrial septal defects [ASD], aortic arch defects, and single-ve

127 Atrial septal defects (ASDs) are a common human congenital hear

128 tions of closure devices for secundum atrial septal defects (ASDs) at a single institution.

129 dysregulation leads to development of atrial septal defects (ASDs) at high frequency.

130 Atrial septal defects (ASDs) can result from haploinsufficiency

131 de Lange syndrome-associated secundum atrial septal defects (ASDs) caused by NIPBL mutations, underta

132 d a high incidence of atrial and ventricular septal defects at birth.

133 transposition of great vessels, ventricular septal defect, atrial septal defect, tetralogy of Fallot

134 onchromosomal CHD (ie, excluding ventricular septal defects, atrial septal defects, and pulmonary val

135 f right dominant unbalanced atrioventricular septal defect (AVSD) remains challenging because unbalan

136 Atrioventricular septal defects (AVSD) are a severe congenital heart defe

137 Atrioventricular septal defects (AVSD) are the most commonly occurring he

138 enesis, resulting in severe atrioventricular septal defects (AVSD).

139 are associated with cardiac atrioventricular septal defects (AVSD).

140 Atrioventricular septal defects (AVSDs) are a common severe form of conge

141 Nonsyndromic atrioventricular septal defects (AVSDs) are an important subtype of CHDs

142 Atrioventricular septal defects (AVSDs) occur as a clinical feature of se

143 years) with large, isolated, secundum atrial septal defects (balloon-stretched diameter >/=34 mm in a

144 cardiography had abnormalities, with ventral septal defects being the most prevalent.

145 defect (SVASD) differs from secundum atrial septal defect by its atrial septal location and its asso

146 ranscatheter closure of muscular ventricular septal defects; (c) the transcatheter closure of perimem

147 A type of ventricular septal defect called the Gerbode defect, which results i

148 Postinfarction ventricular septal defect carries a grim prognosis.

149 ients (6%) in the pitavastatin group (atrial septal defect, chronic obstructive pulmonary disease, ch

150 ocedure (9%), patent foramen ovale or atrial septal defect closure (23%), cardiac metastasectomies or

151 with death after postinfarction ventricular septal defect closure included the following: age (hazar

152 Postinfarction ventricular septal defect closure was attempted in 53 patients from

153 Between 2008 and 2012, atrial septal defect closure with the AMPLATZER Septal Occluder

154 equent concomitant procedures such as atrial septal defect closure, arrhythmia surgery (the maze proc

155 The associations with major ventricular septal defects, common arterial trunk, and anomalous pul

156 nital cardiac malformations like ventricular septal defects, common atrioventricular canal and double

157 ar septal defect, perimembranous ventricular septal defect, conotruncal defects, left ventricular out

158 analyses of probands with heterotaxy, atrial septal defects, conotruncal, and left ventricular outflo

159 r hypertrophy, overriding aorta, ventricular septal defects, coronary vessel abnormalities and valve

160 lities include overriding aorta, ventricular septal defects, cranial nerve, and craniofacial skeletal

161 theter closure of perimembranous ventricular septal defects; (d) the placement of bioprosthetic valve

162 y well-established techniques such as atrial septal defect device closure.

163 atzer Ductal Occluder, the cribriform atrial septal defect device for use in multifenestrated atrial

164 s using the Amplatzer membranous ventricular septal defect device have been encouraging.

165 livery system for the membranous ventricular septal defect device that is aimed to overcome the diffi

166 al septal defects and the fenestrated atrial septal defect device.

167 bserved an accuracy of 89.8% for ventricular septal defect diagnosis.

168 MII-B by 80% results in cardiac (ventricular septal defect, double outlet of the right ventricle) and

169 1-expressing progenitors display ventricular septal defects, double outlet right ventricle, semilunar

170 ardiac anomalies, including atrioventricular septal defects, Ebstein malformation of the tricuspid va

171 ive procedure to create or enlarge an atrial septal defect for the treatment of neonates with hypopla

172 r mille to 4.1 per mille, and of ventricular septal defect from 3.6 per mille to 4.5 per mille.

173 Percutaneous treatment of inter-atrial septal defects has undergone exponential growth in the p

174 perative urgency and postinfarct ventricular septal defect, have been relatively stable over time, wh

175 s, congenital diaphragmatic hernias, cardiac septal defects, hearing loss and autistic and self-injur

176 ersistent truncus arteriosus and ventricular septal defect), hypoplastic lungs, hypoplastic/ectopic k

177 omen had significantly higher ORs for atrial septal defects, hypoplastic left heart syndrome, aortic

178 1, which is associated with atrioventricular septal defect in people with or without DS, and HEY2, wh

179 openia, intermittent neutropenia, and atrial septal defects in 3 members of a consanguineous kindred.

180 ion of both miRNAs causes lethal ventricular-septal defects in approximately half of double-mutant em

181 with ventricular hypoplasia and ventricular septal defects in beta-myosin heavy chain-miR-195 transg

182 hysiology, treatment, and outcomes of atrial septal defects in children and adult patients in whom th

183 ch is demonstrated in characterizing cardiac septal defects in conditional mutant embryos lacking the

184 Because we observed ventricular septal defects in embryos that are null for the PDGFRbet

185 s responsible for heritable atrioventricular septal defects in six lines (avc1-6).

186 on, and partially penetrant atrioventricular septal defects, including ostium primum defects.

187 rged valve cusps, bicuspid aortic valve, and septal defects, indicating that endocardial Jag1 to Notc

188 aneous closure of postinfarction ventricular septal defect is a reasonably effective treatment for th

189 Atrioventricular septal defect is most often found associated with trisom

190 Atrial septal defect is one of the most common forms of congeni

191 mutation in TLL1 was identified in an atrial septal defects kindred and is predicted to affect the en

192 y increased by the presence of a ventricular septal defect, left ventricular outflow obstruction, sur

193 repaired "simple" lesions such as an atrial septal defect may not have normal survival if they are r

194 AV cushion defects including atrial septal defect, membranous VSD, and thickened valve leafl

195 o detected by micro-CT were atrioventricular septal defects (n=22), tricuspid hypoplasia/atresia (n=1

196 rn mice revealed an abundance of ventricular septal defects (n=307).

197 mon diagnoses were Ebstein's anomaly (n=44), septal defects (n=39), and single ventricle (n=36).

198 offspring with a perimembranous ventricular septal defect (odds ratio = 3.23, 95% confidence interva

199 and sulfur dioxide and isolated ventricular septal defects (odds ratio = 2.16, 95% confidence interv

200 in aerodynamic diameter and isolated atrial septal defects (odds ratio = 2.27, 95% confidence interv

201 95% CI, 1.6 to 20.7; 3 exposed subjects) and septal defects (odds ratio, 2.0; 95% CI, 1.2 to 4.0; 13

202 ance, such as cleft palate, choanal atresia, septal defects of the heart, haemorrhages, prenatal deat

203 We identified a new locus linked with atrial septal defect on chromosome 14q12 in a large family with

204 ffected offspring shared an atrioventricular septal defect or a common atrium along with postaxial po

205 clamp times, and the presence of ventricular septal defects or abnormal coronary anatomy.

206 ocardial cushions accompanied by ventricular septal defects, outflow tract abnormalities and atrio-ve

207 The presence of a ventricular septal defect ( P=0.009) and older age at surgery ( P=0.

208 eft superior vena cava (P=0.85), ventricular septal defect (P=0.12), and bicuspid aortic valve (P=0.1

209 ry homograft in 1, and overlying ventricular septal defect patch in 1.

210 annulus, (1B) ventriculotomy-to-ventricular septal defect patch, (2) ventriculotomy-to-pulmonary ann

211 nnulus, (3) pulmonary annulus-to-ventricular septal defect patch, and (4) ventricular septal defect p

212 lar septal defect patch, and (4) ventricular septal defect patch-to-tricuspid annulus.

213 t septum and an appropriate-size ventricular septal defect patch.

214 tflow tract (99%) or the site of ventricular septal defect patching (98%) and in the inferior RV inse

215 to be diagnosed via imaging (secundum atrial septal defect, patent ductus arteriosus, ventricular sep

216 nes relevant for atrial and atrioventricular septal defects, patent ductus arteriosus, bicuspid aorti

217 the transcatheter closure of secundum atrial septal defects, patent foramen ovale, patent ductus arte

218 ventricular septum and TGA with ventricular septal defect performed from 2010 to 2013.

219 rt chambers, interatrial or interventricular septal defects, pericardium, and site and size of the gr

220 of the great arteries, muscular ventricular septal defect, perimembranous ventricular septal defect,

221 defects in the right ventricle, ventricular septal defect, persistent truncus arteriosus, reduced my

222 uding abnormalities of other cardiac valves, septal defects, persistent left superior vena cava, and

223 mily with forelimb anomalies and ventricular septal defects, phenotypes similar to Holt-Oram syndrome

224 erative repair of perimembranous ventricular septal defect (PMVSD) in a large multi-institutional dat

225 theter closure of perimembranous ventricular septal defects (PmVSDs) using the new Amplatzer Membrano

226 efect, patent ductus arteriosus, ventricular septal defect, pulmonary artery anomalies, pulmonary val

227 ricuspid regurgitation, residual ventricular septal defect) reduces this protective association.

228 etween the use of sertraline and ventricular septal defects (relative risk, 1.04; 95% CI, 0.76 to 1.4

229 ents immediately prior to an elective atrial septal defect repair procedure.

230 that haploinsufficient versican mice display septal defects resembling those seen in Crtl1(-/-) embry

231 netically interact in vivo: atrioventricular septal defects result from endothelial-specific Gata4 an

232 e TARP syndrome, talipes equinovarus, atrial septal defect, Robin sequence, and persistent left super

233 evalence of the diagnosis of secundum atrial septal defect rose from 2.3 per mille in 2000-2001 to 7.

234 , but not a mutation causing secundum atrial septal defects (S52F), demonstrated impaired protein int

235 eta led to abnormal heart shape, ventricular septal defects, severe growth retardation, and postnatal

236 l period as well as for muscular ventricular septal defects should be the transcatheter approach.

237 a and microcephaly), heart (atrioventricular septal defect), skeleton (postaxial polydactyly, narrow

238 Periostin null mice exhibit atrial septal defects, structural abnormalities of the AV valve

239 c NSML SHP2 expression developed ventricular septal defects, suggesting that NSML-associated mutation

240 or = 2 loci influence membranous ventricular septal defect susceptibility, whereas > or = loci and at

241 Sinus venosus atrial septal defect (SVASD) differs from secundum atrial septa

242 The superior sinus venosus atrial septal defect (SVASD) is characterized by deficiency of

243 ith IAA associated with sinus venosus atrial septal defect (SVD) and partial anomalous pulmonary veno

244 urgery for atrial septal defect, ventricular septal defect, tetralogy of Fallot, and transposition of

245 t vessels, ventricular septal defect, atrial septal defect, tetralogy of Fallot, coarctation of the a

246 with CHD (atrial septal defect, ventricular septal defect, tetralogy of Fallot, Ebstein anomaly, tra

247 tools, specifically in patients with atrial septal defects, tetralogy of Fallot, single ventricle ph

248 -long-term data for device closure of atrial septal defects, the incidence of late cardiac erosions,

249 ents with isolated atrial and/or ventricular septal defects, the predominant cardiac defects of the H

250 for Percutaneous Closure of Secundum Atrial Septal Defects; this study was approved by the Food and

251 the pilot in vivo study to create an atrial septal defect through the use of extracardiac applicatio

252 nts without prior diagnosis of PFO or atrial septal defect undergoing surgery at the Cleveland Clinic

253 and creation or enlargement of a ventricular septal defect using stents are potential therapeutic opt

254 Closure of large atrial septal defects using the Amplatzer device is safe and ef

255 device closure of perimembranous ventricular septal defects using the Amplatzer membranous ventricula

256 Sudden death after surgery for atrial septal defect, ventricular septal defect, tetralogy of F

257 2 cohorts: (1) all patients with CHD (atrial septal defect, ventricular septal defect, tetralogy of F

258 in the human proband, as well as ventricular septal defect (VSD) and double-outlet right ventricle (D

259 Transcatheter ventricular septal defect (VSD) closure is a safe and efficacious al

260 Ventricular septal defect (VSD) is a lethal complication of acute my

261 Prior ventricular septal defect (VSD) repair predicted neo-AI (p = 0.02) a

262 r atrial septal defect (ASD) and ventricular septal defect (VSD) surgeries in children 2 months to 19

263 erved an increased risk of CHDs, ventricular septal defect (VSD), and tetralogy of fallot (TF) with i

264 g double-outlet right ventricle, ventricular septal defect (VSD), atrioventricular (AV) cushion defec

265 ith intact ventricular septum or ventricular septal defect (VSD), including double-outlet right ventr

266 ongenital heart disease, such as ventricular septal defect (VSD), myocardium noncompaction, and ventr

267 utlet right ventricle (DORV) and ventricular septal defect (VSD), similar to defects observed when ap

268 magnitude of shunting across the ventricular septal defect (VSD).

269 normalities, including PTA and a ventricular septal defect (VSD).

270 as identified with no associated ventricular septal defect (VSD).

271 omes after surgical closure of a ventricular septal defect (VSD).

272 utlet right ventricle (DORV) and ventricular septal defects (VSD).

273 Intramural ventricular septal defects (VSDs) are interventricular communication

274 ntal factors on the incidence of ventricular septal defects (VSDs) caused by a heterozygous Nkx2-5 kn

275 e closure of congenital muscular ventricular septal defects (VSDs) using the new Amplatzer mVSD occlu

276 Ventricular septal defects (VSDs) were associated with the highest b

277 kinking with 100% penetrance and ventricular septal defects (VSDs) with ~15% penetrance; Fz2(+/-);Fz7

278 fects within it, termed muscular ventricular septal defects (VSDs), are common, yet less is known abo

279 enital or postoperative residual ventricular septal defects (VSDs).

280 ith CoA compared with those with ventricular septal defect was determined.

281 In 9 of 10 canines, an atrial septal defect was produced, and shunting across the atri

282 Ventricular septal defect was the most common CHD observed, whereas

283 A large atrial septal defect was the only structural heart disease.

284 Major ventricular septal defects were associated with larger HC relative t

285 Under real-time ultrasound guidance, atrial septal defects were successfully created with extracardi

286 , whereas outflow tract and atrioventricular septal defects were the most prevalent complex CHD.

287 d HEY2, whose mouse ortholog (Hey2) produces septal defects when mutated.

288 X5, another transcription factor that causes septal defects when mutated.

289 luding cardiac noncompaction and ventricular septal defect, which phenocopies 1p36 deletion syndrome

290 ased between 1990 and 2011 except for atrial septal defects, which increased significantly.

291 , ventricular noncompaction, and ventricular septal defects, while, in the postnatal cardiomyocyte, Q

292 tients with CoA and those with a ventricular septal defect, who are not known to be at increased risk

293 MRI demonstrated a ventricular septal defect with over-riding aorta.

294 sposition of the great arteries, ventricular septal defect with pulmonary stenosis (n=8).

295 Closure of atrial septal defect with the AMPLATZER Septal Occluder is safe

296 ethal and had complete atrioventricular (AV) septal defects with a single AV valve and myocardial thi

297 ac ventricular wall thinning and ventricular septal defects with double outlet right ventricle or ove

298 odel a specific subtype of atrio-ventricular septal defects with exclusive ventricular shunting and d

299 Pathology of the hearts showed atrial septal defects with minimal damage to surrounding tissue

300 erior cervical vertebral synostosis, cardiac septal defects with valve dysplasia, and deafness with i